82 related articles for article (PubMed ID: 22192486)
41. Outcomes after accelerated partial breast irradiation in patients with ASTRO consensus statement cautionary features.
McHaffie DR; Patel RR; Adkison JB; Das RK; Geye HM; Cannon GM
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):46-51. PubMed ID: 20732760
[TBL] [Abstract][Full Text] [Related]
42. Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer.
Major T; Niehoff P; Kovács G; Fodor J; Polgár C
Radiother Oncol; 2006 Jun; 79(3):321-8. PubMed ID: 16730085
[TBL] [Abstract][Full Text] [Related]
43. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
[TBL] [Abstract][Full Text] [Related]
44. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.
Antonucci JV; Wallace M; Goldstein NS; Kestin L; Chen P; Benitez P; Dekhne N; Martinez A; Vicini F
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):447-52. PubMed ID: 19058921
[TBL] [Abstract][Full Text] [Related]
45. Treatment volume and dose optimization of MammoSite breast brachytherapy applicator.
Dickler A; Kirk M; Choo J; Hsi WC; Chu J; Dowlatshahi K; Francescatti D; Nguyen C
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):469-74. PubMed ID: 15145164
[TBL] [Abstract][Full Text] [Related]
46. Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial.
Nelson JC; Beitsch PD; Vicini FA; Quiet CA; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Whitworth PW; Fine RE; Keleher AJ; Kuerer HM
Am J Surg; 2009 Jul; 198(1):83-91. PubMed ID: 19268900
[TBL] [Abstract][Full Text] [Related]
47. Modeling study for optimization of skin dose for partial breast irradiation using Xoft Axxent electronic brachytherapy applicator.
Hepel JT; Hiatt JR; Cardarelli GA; Wazer DE
Brachytherapy; 2010; 9(1):81-5. PubMed ID: 19850533
[TBL] [Abstract][Full Text] [Related]
48. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast.
Jeruss JS; Vicini FA; Beitsch PD; Haffty BG; Quiet CA; Zannis VJ; Keleher AJ; Garcia DM; Snider HC; Gittleman MA; Whitacre E; Whitworth PW; Fine RE; Arrambide S; Kuerer HM
Ann Surg Oncol; 2006 Jul; 13(7):967-76. PubMed ID: 16788759
[TBL] [Abstract][Full Text] [Related]
49. Perioperative brachytherapy for pretreated chest wall recurrence of breast cancer.
Mayer A; Naszály A; Patyánik M; Zaránd P; Polgár I; Klinkó T
Strahlenther Onkol; 2002 Nov; 178(11):633-6. PubMed ID: 12426674
[TBL] [Abstract][Full Text] [Related]
50. First clinical implementation of the Capri applicator.
Gloi AM
J Appl Clin Med Phys; 2014 Jan; 15(1):4581. PubMed ID: 24423857
[TBL] [Abstract][Full Text] [Related]
51. Early side effects of three-dimensional conformal external beam accelerated partial breast irradiation to a total dose of 40 Gy in one week (a phase II trial).
Bourgier C; Pichenot C; Verstraet R; El Nemr M; Heymann S; Biron B; Delaloge S; Mathieu MC; Garbay JR; Bourhis J; Taghian AG; Marsiglia H
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1228-35. PubMed ID: 20932662
[TBL] [Abstract][Full Text] [Related]
52. Comparison of planning techniques when air/fluid is present using the strut-adjusted volume implant (SAVI) for HDR-based accelerated partial breast irradiation.
Harmon JF; Rice BK
J Appl Clin Med Phys; 2013 Nov; 14(6):4442. PubMed ID: 24257287
[TBL] [Abstract][Full Text] [Related]
53. Strut-adjusted volume implant (SAVI) brachytherapy-based accelerated partial breast irradiation (APBI) in African American women.
Isbell A; Dunmore-Griffith J; Abayomi O
Breast Cancer Res Treat; 2017 Feb; 162(1):69-76. PubMed ID: 28070767
[TBL] [Abstract][Full Text] [Related]
54. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
[TBL] [Abstract][Full Text] [Related]
55. A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD).
Luxton G; Keall PJ; King CR
Phys Med Biol; 2008 Jan; 53(1):23-36. PubMed ID: 18182685
[TBL] [Abstract][Full Text] [Related]
56. Accelerated partial breast irradiation using interstitial high dose rate iridium brachytherapy: Early Australian experience and review of the literature.
Stevens MJ; Cooper SG; Cross P; Wang Y
Australas Radiol; 2006 Apr; 50(2):143-51. PubMed ID: 16635033
[TBL] [Abstract][Full Text] [Related]
57. SU-E-T-322: A Dosimetric Comparison of PBI Brachytherapy Techniques: SAVI, Contura, and Tube and Button Applicators.
Park S; Kamrava M; Demanes J
Med Phys; 2012 Jun; 39(6Part14):3778. PubMed ID: 28517257
[TBL] [Abstract][Full Text] [Related]
58. SU-E-T-236: Brachytherapy for Breast Cancer Patients with Implanted Pacemeker, Using Multi Lumen Partial Breast Applicator.
Jacob D; Strasser J
Med Phys; 2012 Jun; 39(6Part13):3757. PubMed ID: 28517320
[TBL] [Abstract][Full Text] [Related]
59. Dosimetry evaluation of SAVI-based HDR brachytherapy for partial breast irradiation.
Manoharan SR; Rodriguez RR; Bobba VS; Chandrashekar M
J Med Phys; 2010 Jul; 35(3):131-6. PubMed ID: 20927219
[TBL] [Abstract][Full Text] [Related]
60. Analysis of applicator displacement in accelerated partial breast irradiation using a strut-based design brachytherapy applicator.
Kubo T; Kurokawa C; Inoue T; Fujii T; Miyaura K; Shinjo H; Kagami Y; Shikama N
Brachytherapy; 2023; 22(5):655-664. PubMed ID: 37455152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
